Hasil Pencarian - L. E. Budde

  • Menampilkan 1 - 7 hasil dari 7
Perbaiki Hasil
  1. 1
    ON THE DEVELOPMENT OF A DATASET PUBLICATION GUIDELINE: DATA REPOSITORIES AND KEYWORD ANALYSIS IN ISPRS DOMAIN

    ON THE DEVELOPMENT OF A DATASET PUBLICATION GUIDELINE: DATA REPOSITORIES AND KEYWORD ANALYSIS IN ISPRS DOMAIN oleh L. E. Budde, T. Kullmann, D. Iwaszczuk

    Diterbitkan 2023-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    IDENTIFICATION OF MISCLASSIFIED PIXELS IN SEMANTIC SEGMENTATION WITH UNCERTAINTY EVALUATION

    IDENTIFICATION OF MISCLASSIFIED PIXELS IN SEMANTIC SEGMENTATION WITH UNCERTAINTY EVALUATION oleh L. E. Budde, D. Bulatov, D. Iwaszczuk

    Diterbitkan 2021-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    CURRENT STATUS OF THE BENCHMARK DATABASE BEMEDA

    CURRENT STATUS OF THE BENCHMARK DATABASE BEMEDA oleh L. E. Budde, J. Schmidt, T. Kullmann, D. Iwaszczuk

    Diterbitkan 2023-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    DEVELOPMENT OF A DATABASE FOR BENCHMARK DATASETS IN PHOTOGRAMMETRY AND REMOTE SENSING

    DEVELOPMENT OF A DATABASE FOR BENCHMARK DATASETS IN PHOTOGRAMMETRY AND REMOTE SENSING oleh L. E. Budde, J. Schmidt, A. Javanmard-Ghareshiran, S. Hunger, D. Iwaszczuk

    Diterbitkan 2022-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    P1124: MOSUNETUZUMAB RETREATMENT IS EFFECTIVE AND WELL-TOLERATED IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL NON-HODGKIN LYMPHOMA

    P1124: MOSUNETUZUMAB RETREATMENT IS EFFECTIVE AND WELL-TOLERATED IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL NON-HODGKIN LYMPHOMA oleh C. Y. Cheah, N. L. Bartlett, S. Assouline, S. J. Schuster, W. Seog Kim, M. Shadman, I. Isufi, S. Yin, M. Y. Doral, J. Sit, V. Chen, H. Huang, M. Zhou, M. C. Wei, L. E. Budde

    Diterbitkan 2022-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    P1126: MOSUNETUZUMAB IS EFFICACIOUS AND WELL TOLERATED IN PATIENTS AGED <65 AND ≥65 YEARS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA AND ≥2 PRIOR THERAPIES: SUBGROUP ANALYSIS OF A PIVOTAL PHASE II STUDY

    P1126: MOSUNETUZUMAB IS EFFICACIOUS AND WELL TOLERATED IN PATIENTS AGED <65 AND ≥65 YEARS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA AND ≥2 PRIOR THERAPIES: SUBGROUP ANALYSIS OF... oleh M. Matasar, N. L. Bartlett, L. H. Sehn, S. J. Schuster, S. Assouline, P. Giri, J. Kuruvilla, M. Canales, S. Dietrich, K. Fay, M. Ku, L. J. Nastoupil, M. C. Wei, S. Yin, I. To, D. Turner, H. Huang, J. Min, E. Penuel, L. E. Budde

    Diterbitkan 2022-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    P1454: REAL-WORLD OUTCOMES OF BREXUCABTAGENE AUTOLEUCEL (BREXU-CEL) FOR THE TREATMENT OF RELAPSED OR REFRACTORY (R/R) MANTLE CELL LYMPHOMA (MCL) IN THE UNITED STATES (US)

    P1454: REAL-WORLD OUTCOMES OF BREXUCABTAGENE AUTOLEUCEL (BREXU-CEL) FOR THE TREATMENT OF RELAPSED OR REFRACTORY (R/R) MANTLE CELL LYMPHOMA (MCL) IN THE UNITED STATES (US) oleh F. Locke, MD, Z.-H. Hu, MPH, J. Gerson, MD, M. J. Frank, PhD, L. E. Budde, PhD, M. Wang, MD, B. Logan, PhD, I. Kloos, PhD, R. Siddiqi, PhD, J. Shah, MD, H. Xu, PhD, M. Pasquini, MS

    Diterbitkan 2022-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: